Psychedelics Today

In this episode, Kyle sits down with Dylan Beynon, founder of Mindbloom, NYC based mental health and wellbeing platform. In the show they talk about how Mindbloom differs from other centers, paving the way for accessibility and affordability. 3 Key Points: Mindbloom is a next-generation mental health platform, catered to accessibility and affordability. They use ketamine tablets, different from lozenges and any other method. The tablets are held in the mouth and then spit out to avoid entering the liver, causing a sedation-like experience. Mindbloom differentiates themselves from other psychedelic therapy options by using a patient-choice model, to keep it affordable for those who need it. They offer the 4-week therapy model and give patients the option to choose ‘add-ons’ like extra integration.  Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcast, etc Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating

In this episode, Kyle sits down with Dr. Ryan Westrum, Psychedelic Integration Therapist. In the show, they talk about topics and teachings from Ryan’s book, The Psychedelic Integration Handbook. 3 Key Points: The Psychedelics Integration Handbook is designed to bring psychedelic experiences into the flow of your life and maximize their potential for helping you create the life you want to live. There is an important part in distinguishing integration from aftercare. Aftercare can look as simple as taking care of your body, getting good rest, eating well. You can't integrate without taking care of yourself first. One of the pillars of integration is PREP (purpose, reflecting on experiences, expectations, potential). Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcast, etc Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating Psychedelics Show Notes About Ryan Ryan is a Clinical Psychologist in the Minn

In this episode, Kyle interviews Jessica DiRuzza, Psychotherapist, Astrologer and Teacher. In the show they talk about how astrology can be used as a tool and framework for navigating and understanding psychedelic experiences. 3 Key Points: Astrology can be used as an integrative tool for psychedelic and other exceptional experiences. The planets are emitting some type of force that are letting us behave a certain way. Astrology is the one thing we have agreed upon across millennia and era. A Saturn Return transit can be a difficult but transformative time in one's life. This transit happens around age 28-31. During this time, we face crises in our life as we take on greater responsibility. It can feel like death and a rebirth. It can correlate to Grof's Perinatal Birth Matrix II (“No Exit” and "Cosmic Engulfment").  Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcast, etc Join our Facebook group - Psychedelics Today group – Find the others and create co

In this episode, Kyle sits down with Rob Heffernan, an independent researcher and activist. In the show, they talk about churches, Ayahuasca, accessibility and the Psychedelic Liberty Summit by the Chacruna Institute for Psychedelic Plant Medicines. Rob is also part of Chacruna’s Council for the Protection of Sacred Plants.  The Council for the Protection of Sacred plants is "an initiative of the Chacruna Institute for Psychedelic Plant Medicines that endeavors to advocate for the legality of sacred plant medicines among indigenous peoples and non-indigenous communities, encourage legal harm reduction practices that protect those who use them, educate about conservation of plant species, document relevant legal and social issues, and consult on legal cases including possible litigation. "  3 Key Points: The Psychedelic Liberty Summit is a gathering on legal, cultural, and political issues around the emerging psychedelic renaissance. Accessibility is not just about whether or not people can afford psychedelic

In this episode, Joe interviews Clinical Psychologist, Alicia Danforth. In the show, they cover topics including how to get involved in the space, consent, research, MDMA, Autism and more. 3 Key Points: Alicia Danforth is a Clinical Psychologist who will be having a talk on Ethical Challenges in Psychedelic Medicine at the ICPR Conference in the Netherlands, April 2020. There is a possibility for MDMA to have a non-responder effect. No one has done research dedicated to why some people don't react at all to MDMA. Psychedelic science is very hard to talk about. We have the language of science that studies the psychopharmacological effects of drugs but no language that holds the effects of an altered state of consciousness yet. Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcast, etc Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating Psychedelics Show Notes About Alicia Her path to her current place is

In this episode, Kyle and Joe interview Mike Margolies of Psychedelic Seminars. In the show, they cover topics including guests and conversations from the Psychedelic Seminars, the decriminalization of all drugs, and the importance of allowing psychedelic use to be a part of training therapists for psychedelic therapy. 3 Key Points: Psychedelic Seminars is an educational conversation series deepening awareness of the benefits, risks, and complexities of psychedelics. There are large topics of decriminalizing psilocybin or the movements for ‘decriminalize nature’, but the conversation on decriminalization of all drugs is rare, which is what's really important. Some companies (MAPS for example) allow the option to use MDMA as a part of their therapist training program while other companies who are training therapists for psilocybin therapy, don't have the option to use it. This leaves the question, "Should the psychedelic experience be part of the psychedelic therapy training?"  Support the show Patreon Le

In this Episode, Kyle sits down with Elizabeth Nielson and Ingmar Gorman, Co-founders of Fluence, Training in Psychedelic Integration. They are both therapists on the MAPS clinical trial for MDMA Assisted Psychotherapy for PTSD. 3 Key Points: Elizabeth and Ingmar are co-founders of Fluence, an online Psychedelic Integration Training program. If psychedelic treatments become available more widely, the fear is that therapists won't be as educated on how to handle their patient interactions based on the behavior of each psychedelic. Psychedelic Integration Therapy Training is so important. There are 3 phases to the MDMA for PTSD clinical trial. Phase 1 would be pre-clinical data about the chemistry of a drug, Phase 2 is where you begin to test your treatment in a patient population, and Phase 3 is where you get the data to demonstrate that the treatment is superior to a placebo and other treatments in general. Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcas

In this episode, Joe interviews Jon S. on his experience in the psilocybin-assisted trials for alcohol dependency at NYU. In the show, they dive into Jon’s background and how psilocybin assisted therapy helped him out of his alcohol dependence and into a new life. 3 Key Points: Jon participated in the NYU Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence. The study was double-blind. In each session, he didn't know if he was going to receive psilocybin or Benadryl.  The sessions helped him so much with this dependence on alcohol, he believes he is a better father, husband, and human overall. He hasn't had a drink in 5 months (or a desire to).  Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcast, etc Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating Psychedelics Show Notes About Jon He is based in New York Jon is the father of 2 kids He spent a lot of his life DJing, so he has

In this episode, Joe interviews Joost Breeksema from the Netherlands to talk about the Interdisciplinary Conference on Psychedelic Research. In the show they cover topics on ICPR 2020, and the importance of accessibility. 3 Key Points: The Interdisciplinary Conference on Psychedelic Research takes place April 24-26, 2020 in the Netherlands. It's important to acknowledge the indigenous, ethical, and political dimensions to psychedelic use at conferences. Although this conference will be catered toward mainstream science and research, personal experiences and stories are important too. Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcast, etc Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating Psychedelics Show Notes About Joost Joost is a part of the OPEN Foundation ICPR is a huge conference Nobody before was doing research on psychedelics in the Netherlands William James work sparked Joost’s interest

In this episode, Kyle invites a guest interviewer, Hallie Rose of the Thought Room Podcast, to interview him on his recent experience at Soltara. In the show, they talk about Soltara, Kyle’s experience with the plant medicine, and important topics like privilege.  3 Key Points: Eastern attendees have a different integration need than Western attendees. In the West, attendees come back to more hustle and bustle, more time is needed for integration. Soltara does a really good job at providing that time for integration.   With Psilocybin and other psychedelics, there is this one big door, you eat the mushrooms and open the door and get to experience it heavily. With Ayahuasca, there is a smaller doorway to penetrate through, you have to create a relationship with the medicine first. If the people that really need the help can't even afford it, then how do we have mass healing? Peer support movements are a way forward in this issue. Support the show Patreon Leave us a review on iTunes Share us with your f

This disclaimer was originally posted in our episode, Treating Social Anxiety in Adults with Autism with MDMA and LSD – Voices in the Dark, and it feels important to post it on this episode as well.  Caution/Disclaimer A few important notes. This is an episode of an individual experimenting with powerful drugs to see if he can get any sort of relief from autism. In this case, it appears to have been successful. That said, this came with a substantial amount of risks, and people need to be aware. Please read the below bullets so you understand.  Autism is not what is treated. The thing being treated would be a symptom like social anxiety. "The field of autism science includes a long and shameful history of quack treatments and parents taking desperate and harmful measures to “fix” their children. Autism is a spectrum of congenital and neurocognitive variants, and there are no published research data in support of any compound that can influence its course." Alicia Danforth, PhD Please do not administer these

In this episode, Kyle and Joe interview previous guest of the show, Daniel Greig. In the show, he goes in depth into the meaning of enlightenment and previews the new book he is writing with Dr. John Vervaeke, The Cognitive Continuum. 3 Key Points: Insight, flow and mystical experiences are all facets of working toward enlightenment. Enlightenment is really a fundamental grip on reality. It's about maintaining a relationship with the transcendent, it's not about just constantly escaping this body life. The mystical experience is a glimpse at consciousness. The most important part of having a mystical (psychedelic) experience is coming back into our bodies and developing better relationships with ourselves, others and the world. Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcast, etc Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating Psychedelics Show Notes The Cognitive Continuum There will be a crow

In this episode, Kyle and Joe interview Chris Bache, author of LSD and the Mind of the Universe. Chris went through 73 high dose LSD sessions and talks about his experience in the show. 3 Key Points: Chris went through 73 high dose LSD sessions, but he says that pushing the edge of high dose and high frequency use brought on increasingly intense difficulties. He does not recommend high dose sessions like he did. The mind of the universe is where someone goes when one completely dissolves. In the show, they discuss psychedelic therapy and the debate on whether or not therapists should have to have psychedelic experience to do the therapy. Chris believes that the level of experience a therapist has had will impact the type of support they will be able to give. Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcast, etc Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating Psychedelics Show Notes Psychedelic In

In this episode, Joe interviews Dr. Peter Addy, Licensed Mental Health Counselor out of Washington. In the show, they talk about the research and therapeutic use of Salvia. 3 Key Points: Salvinorin A is the active molecule that causes the psychedelic experiential reports, although there are at least a dozen unique compounds in the Salvia plant. In a recreational setting, Salvia is usually smoked, but in the Mazatec culture, they do not smoke it, they use a sublingual method. The clinical applications of Salvia are tricky right now. It's not easy to get funding for psychedelic research. Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcast, etc Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating Psychedelics Show Notes About Peter Peter helped found the Yale Psychedelic Speaker Series The main goal was to normalize talking about psychedelic research as research Peter joined the pharmacology lab for his

In today’s episode, Joe visits Naropa in Boulder, CO to sit down with Rafael Lancelotta and Alan Kooi Davis. Alan is a Clinical Psychology Professor at Ohio State and Rafael is a legal Psychedelic Therapist operating out of Innate Path in Colorado. 3 Key Points: Facilitation is a huge problem in the 5-MEO-DMT space. Some people take it without the intention of working on it afterward, they are commonly given too much, and also in a poor context. This recipe of poor facilitation and guidance leads to a lot of challenging experiences and a lot of integration work. The feeling of oneness typically arises when taking 5-MEO-DMT. It can be great for some, but for others, it can be extremely overwhelming and harmful when not provided the correct intention, context and tools to work through it. Privilege is a huge issue in the psychedelic space. The goal in this space is to make everyone’s voice heard, not just those of privilege. Support the show Patreon Leave us a review on iTunes Share us with your friends –

In today’s episode, Joe interviews Mike Jay, Author of the book, Mescaline: A Global History of the First Psychedelic. In the show they discuss Mescaline’s origins and the history of Peyote use. 3 Key Points: Mike Jay is a Cultural Historian and Author whose topics include science, medicine, drugs, madness, literature and radical politics. Mike’s recent book, Mescaline, is a definitive history of mescaline that explores its mind-altering effects across cultures, from ancient America to western modernity. Over time, Peyote has been used by spiritual seekers, by psychologists investigating the secrets of consciousness, artists exploring the creative process, and by psychiatrists. Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcast, etc Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating Psychedelics Show Notes About Mike Mike Jay is a freelance writer, an author and cultural historian Mike has been

In this episode, Joe interviews Dena Justice from the Ecstatic Collective. Dena and Joe talk about Neuro Linguistic Programming and how it is beneficial to use with non-ordinary states of consciousness. 3 Key Points: NLP is Neuro Linguistic Programming. Dena Justice is a Lifestyle Design Strategist that uses NLP to help people create their dream, ecstatic life. 93% of communication happens at the subconscious level. NLP training focuses on how we use communication tools to help people in non-ordinary states of consciousness. Perception is Projection. Our belief of someone else, is a projection of ourselves onto them. Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcast, etc Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating Psychedelics Show Notes About Dena Dena grew up with NLP in her life NLP is Neuro Linguistic Programming “You get to create your reality, what are you choosing consciously?” - Dena

In this episode, Kyle sits down with Raquel Bennett to recap on the KRIYA Conference. Kyle attended the conference, which is to bring people together with dedication to understanding the better use of Ketamine. 3 Key Points: The more recent KRIYA Conference was the last of its kind. The goal is to make information on ketamine more accessible to more people in the future. At KRIYA Institute, they believe that there is not one right way to use ketamine, different patients are best served by different treatment strategies. Intramuscular ketamine is usually 93% bioavailable, while nasal and lozenge based ketamine is usually only 40% bioavailable. The less variability the better when working with a powerful medicine for therapy. Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcast, etc Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating Psychedelics Show Notes KRIYA KRIYA is an international conference focus

In today’s episode, Joe sits down with Andy Frasco, a touring rock musician with the band, Andy Frasco and the UN. In the show, they cover what is it like to be a touring rock musician with drugs so available and how to live more healthfully in the space. 3 Key Points: Andy Frasco is a talented, touring music artist a part of the band, Andy Frasco and the UN, as well as a podcast show host. Andy uses psychedelics to help cope with the anxiety that the rock star lifestyle brings. Psychedelics open us up to the possibility that everything we know is wrong. Finding truth and clarity for some people is hard, and people resort to alcohol and other harmful behaviors to suppress the painful reality we live in. Cocaine and uppers only keep a rock star up for so long. It keeps you awake for the partying, but it suppresses all the stresses of the lifestyle. Psychedelics and meditation can help with the balance needed in a stressful, lifestyle of traveling and fame. Support the show Patreon Leave us a review on iT

In this episode, Kyle and Joe sit down to cover questions from listeners of the show. They discuss topics that include psychedelic use for exorcisms, cluster headaches, athletic performance, processing grief and more. 3 Key Points: There are a few examples where psychedelics are used to increase athletic performance. Psychedelics can also be used to help realign those who are using sports as a form of distraction from internalized issues. When eliminating variables for psilocybin consistency in mushrooms for therapeutic use, freeze drying helps. But there are so many variables in mushrooms versus synthesized psilocybin. When addressing the sustainability of the Toad, according to the data, there isn't a real difference between 5-MEO-DMT from a toad and synthesized 5-MEO-DMT Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcast, etc Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating Psychedelics Show Note